Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · ASTEC

ASTEC LIFE

CommoditiesFertilizers & Agrochemicals₹1223 cr market cap
₹546.05 ▼ -0.42% today As of 19 Nov 2026
52-week low ₹521.8552-week high ₹918.75

-40.3% from the 52-week high · +5.1% above the low

Astec LifeSciences Ltd. engages in the manufacture and sale of agrochemicals and pharmaceutical intermediates. The company is headquartered in Mumbai, Maharashtra and currently employs 551 full-time employees. The company went IPO on 2009-11-25. The firm operates through the Agrochemicals segment. The company manufactures a range of fungicides, insecticides, herbicides, and intermediates for its global customers. The Company’s products and intermediates includes triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, silane derivatives, fluorinated aromatic, aliphatic and heterocyclic intermediates, fluorinated aromatic amines, fluorinated pyridine derivatives, fluorinated aromatic carboxylic acids, fluorinated benzyl alcohols, fluorinated ketones and benzophenones, fluorinated heterocyclic mercaptans, heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, thorium salts, pyrazalone’s and heterocyclic sulfonyl chlorides.

The short version. ASTEC LIFE reported revenue of ₹72 crore for Sep 2026, down 2.7% from a year earlier. Net profit was ₹-37 crore. Return on equity was -20.7% in Mar 2026. Promoter holding was 71.96% in Sep 2026, up 5.21 points over 8 quarters.

1 · The price

How has the stock traded?

ASTEC LIFE trades 40.3% below its 52-week high and 5.1% above its 52-week low.

Change over period: —

1M-21.2%
3M-9.2%
6M-27.0%
1Y-15.6%

2 · The business

Is it growing?

Sales, year on year-2.7%

Sep 2026 revenue of ₹72 cr.

Net margin-51.9%

18.8 pts lower than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue7284159125749112094
Net profit-37-19-8-16-24-33-16-40
Net margin %-51.9-22.4-4.9-12.6-33.1-36.3-13.5-43.0
EPS (₹)-16.79-8.4-3.48-7.04-10.96-14.74-7.18-18.02

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue448381458628677555523431
Net profit-81-135-472690654836
Net margin %-18.1-35.3-10.24.113.311.79.18.3
EPS (₹)-36.31-60.12-20.9411.4140.1229.0721.2415.99

3 · The quality

How well does it turn capital into profit?

Return on equity was -20.7% in Mar 2026; debt to equity is 1.15.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %-20.7-57.4-12.76.1
Return on capital %-10.5-20.2-6.312.3
EBITDA margin %-0.3-15.7-0.113.9
Net margin %-17.8-34.8-10.14.0

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR-10.9%-4.2%
Profit CAGR——
Debt to equity1.15
Interest cover-1.4x
Current ratio0.89

4 · The owners

Who holds it, and are they adding?

Promoter holding71.96%

Up 5.21 pts over 8 quarters.

Foreign institutions0.03%

Down 1.17 pts over 8 quarters.

Domestic institutions3.34%

Down 2.07 pts over 8 quarters.

Mutual fund schemes3

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter66.7570.8770.8772.4271.9771.9771.9671.96+5.21
FII1.20.250.0200.040.020.010.03-1.17
DII5.414.344.264.013.173.343.333.34-2.07
Public26.6424.5424.8423.5724.8224.6724.6924.67-1.97

Mutual fund holdings · Oct 2026

3 schemes hold this stock

3 the month before.

  • ICICI Prudential Commodities Fund0.18% of NAV
  • NIPPON INDIA SMALL CAP FUND0.04% of NAV
  • ICICI Prudential Mid Cap Fund0.01% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for ASTEC LIFE are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about ASTEC LIFE

What is the ASTEC LIFE share price?

ASTEC LIFE (ASTEC) last closed at ₹546.05, down 0.42% on the day. Its 52-week range is ₹521.85 to ₹918.75.

What is the market cap of ASTEC LIFE?

ASTEC LIFE has a market capitalisation of about ₹1,223 crore.

How are ASTEC LIFE's latest results?

ASTEC LIFE reported revenue of ₹72 crore for Sep 2026, down 2.7% from a year earlier. Net profit was ₹-37 crore. Return on equity was -20.7% in Mar 2026. Promoter holding was 71.96% in Sep 2026, up 5.21 points over 8 quarters.

Who owns ASTEC LIFE?

As of Sep 2026, shareholding was: Promoter 71.96%, FII 0.03%, DII 3.34%, Public 24.67%.

How many mutual funds hold ASTEC LIFE?

3 mutual fund schemes held ASTEC LIFE in October 2026. That compares with 3 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 04 Jul 2025 · Rights issue 1:7
  • 21 Jul 2023 · Final Dividend - Rs. 1.5
  • 19 Jul 2022 · Final Dividend - Rs. 1.5
  • 22 Jul 2021 · Final Dividend - Rs. 1.5
  • 16 Jul 2020 · Final Dividend - Rs. 1.5
  • 18 Jul 2019 · Final Dividend - Rs. 1.5

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.